Complement-Based Drug Development Summit leaderboard
  • Wednesday, August 19, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 72

Author

Pharma Journalist 9007 posts 0 comments

Quotient Sciences and CPI Launch Joint Venture to Speed Up RNA Drug Development

Sep 4, 2025
Quotient Sciences, a global leader in drug development and manufacturing acceleration, has joined forces with UK technology innovation centre CPI to form a joint venture (JV) focused on…
Read More...

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, NJ Site

Sep 3, 2025
Thermo Fisher Scientific Inc. announced the completion of its acquisition of Sanofi’s sterile fill-finish and packaging facility in Ridgefield, New Jersey, expanding its strategic…
Read More...

OMass Therapeutics Partners with Genentech to Develop Inflammatory Bowel Disease Therapies

Sep 3, 2025
OMass Therapeutics, a biotech company specializing in medicines targeting complex protein ecosystems, has entered into an exclusive collaboration and license agreement with Genentech, a…
Read More...

FDA Approves Henlius and Organon’s BILDYOS and BILPREVDA Biosimilars to PROLIA and XGEVA

Sep 3, 2025
Shanghai Henlius Biotech, Inc. and Organon have announced that the U.S. Food and Drug Administration (FDA) has approved BILDYOS (denosumab-nxxp) and BILPREVDA (denosumab-nxxp),…
Read More...

Boehringer’s HERNEXEOS Approved in China as First Oral Targeted Therapy for HER2-Mutant Advanced…

Sep 3, 2025
Boehringer Ingelheim announced that its drug HERNEXEOS (zongertinib tablets) has received approval from China’s National Medical Products Administration (NMPA) as a monotherapy…
Read More...

FDA Approves LEQEMBI IQLIK Subcutaneous Injection for Early Alzheimer’s Maintenance Therapy

Sep 1, 2025
Eisai Co., Ltd. and Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for LEQEMBI IQLIK (lecanemab-irmb)…
Read More...

Santhera Partners with Ikris Pharma Network to Distribute AGAMREE in India

Sep 1, 2025
Santhera Pharmaceuticals has entered into an exclusive agreement with Ikris Pharma Network to distribute AGAMREE (vamorolone) in India. The drug is approved for treating Duchenne…
Read More...

Sanofi’s Wayrilz Approved in US as First BTK Inhibitor for Immune Thrombocytopenia

Sep 1, 2025
The U.S. Food and Drug Administration (FDA) has approved Wayrilz (rilzabrutinib), an oral Bruton’s tyrosine kinase (BTK) inhibitor, for adults with persistent or chronic immune…
Read More...

Novartis’ Leqvio Achieves Early LDL-C Goals with Less Muscle Pain

Sep 1, 2025
Novartis has announced encouraging results from its Phase IV V-DIFFERENCE study, which evaluated Leqvio (inclisiran) in patients with high cholesterol who had not met…
Read More...

Heidelberg Pharma Partner Telix Pharmaceuticals Provides Regulatory Update on Imaging Agent…

Aug 29, 2025
Heidelberg Pharma AG announced that its licensing partner, Telix Pharmaceuticals, has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA)…
Read More...
Prev Next
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Fulcrum and Slate Medicines Agree to $245 Million Merger
  • LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases
  • Sandoz and Henlius Expand Global Biosimilar Collaboration
  • FDA Grants Fast Track Status to Spevatamig for Biliary Cancer
  • EMA Validates Pfizer and Valneva Lyme Disease Vaccine Application

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

Advancing Respiratory Medicine Following ATS – What Now?

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.